Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery
Launched by BRANCH OFFICE OF "HADASSAH MEDICAL LTD" · Apr 15, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different techniques for breast reconstruction after surgery for early-stage breast cancer (stages 0 to II). The researchers want to find out which method is better for keeping the breast implant in place and reducing complications. They will compare a synthetic mesh called polytetrafluoroethylene (PTFE) with allogeneic dura mater, which is a type of tissue used in surgery. The trial aims to see how well each technique works in terms of maintaining the shape of the breast and how satisfied patients are with their results.
To participate in this study, you need to be a white woman diagnosed with early-stage breast cancer who is planning to have breast reconstruction. If you join, you'll have surgery where either the PTFE mesh or the dura mater will be used to support the breast implant. After surgery, the researchers will monitor you for six months to check for any complications and will ask you to complete a questionnaire about how satisfied you are with the results. This research is important because it will help doctors understand the best ways to perform breast reconstruction and improve patient outcomes.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • White women;
- • Breast cancer stage 0-II;
- • Indications for breast reconstruction;
- • Consent to participate in the study and photographic documentation.
- Exclusion Criteria:
- • Non-white women;
- • Breast cancer stage III-IV;
- • Tubular breast;
- • Mental and cognitive health disorders;
- • Failure to comply with recommendations in the postoperative period (premature physical activity, not wearing compression underwear, missing scheduled visits, refusal of photo documentation);
- • Patient refusal to participate in the study at any stage.
About Branch Office Of "Hadassah Medical Ltd"
Hadassah Medical Ltd. is a prominent healthcare organization renowned for its commitment to advancing medical research and clinical innovation. The branch office serves as a pivotal hub for conducting clinical trials, focusing on cutting-edge therapies and treatment modalities across various medical disciplines. With a dedicated team of experienced professionals and access to state-of-the-art facilities, the branch office of Hadassah Medical Ltd. is dedicated to ensuring the highest standards of patient care and safety while contributing to the advancement of medical knowledge and practice. Through its collaborative approach, the office aims to foster breakthroughs that enhance patient outcomes and improve healthcare delivery globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, Skolkovo Innovation Center, Russian Federation
Patients applied
Trial Officials
Alla Kartasheva, PhD
Principal Investigator
The Branch of Hadassah Medical LTD
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported